1. Time to clinical benefit of dapagliflozin and significance of prior heart failure hospitalization in patients with heart failure with reduced ejection fraction;Berg;JAMA Cardiol,2021
2. Sodium-glucose cotransporter 2 inhibition for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: a systematic review and meta-analysis;Arnott;J Am Heart Assoc,2020
3. American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan—2022 update;Blonde;Endocr Pract,2022
4. 16. Diabetes care in the hospital: standards of care in diabetes—2024;Diabetes Care,2024
5. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Heidenreich;Circulation,2022